NISSHA Acquires Vietnamese Medical Device Manufacturer USM HEALTHCARE as Subsidiary – M&A Online

News Highlights

NISSHA has acquired a stake in USM HEALTHCARE, a Vietnamese medical device manufacturer, making it a subsidiary. This M&A is seen as part of NISSHA’s strategy to accelerate the global expansion of its medical business. Against the backdrop of increasing demand for medical devices in the Vietnamese market, the company aims to strengthen its business foundation by deepening collaboration with local enterprises. While specific details such as the acquisition amount and NISSHA’s shareholding ratio have not been disclosed, its growth strategy in the medical device sector is noteworthy.

M&A Medical Editorial Department’s Perspective

NISSHA’s acquisition of Vietnamese USM HEALTHCARE as a subsidiary is noteworthy as a case that demonstrates new possibilities for “business succession” facing managers and successors of domestic medical institutions. In particular, the fact that USM HEALTHCARE has a business foundation as a medical device manufacturer within Vietnam is important. This suggests that domestic medical institutions have room to consider more dynamic options such as acquiring or partnering with overseas medical device manufacturers for the continuation and development of their own institutions. Beyond simple third-party succession within Japan, business restructuring from a global perspective and the creation of synergy with overseas companies that can leverage the strengths of one’s own institution will become more realistic as future management strategies. This move can be said to encourage a broader and more strategic approach for domestic medical institutions to overcome the problem of lack of successors.

Points Highlighted by This News

• Suggests the possibility of domestic medical institutions considering business succession through the acquisition or partnership with overseas medical device manufacturers.
• Demonstrates that business development in a growth region like the Vietnamese market can be a target for M&A of medical device manufacturers.
• It is part of NISSHA’s global strategy and captures a segment of the international business restructuring movement in the medical device field.
• Highlights the existence of broader strategic options, not limited to domestic ones, for overcoming the issue of successor absence.

Practical Questions Arising from This News

• What were the specific business scale of USM HEALTHCARE and the synergies NISSHA aimed to achieve through the acquisition?
• What is the projected growth rate of the Vietnamese medical device market specifically?
• How will this M&A affect NISSHA’s future global expansion in its medical business?

If You Feel “Should I Consult Too?”

To managers seeking options other than “closure” or “liquidation.” As exemplified by NISSHA’s case, business succession is not limited to domestic options. It is an era where one should consider collaboration with overseas companies that can leverage their institution’s strengths and the possibility of business expansion through M&A. In particular, global expansion in the medical device field can be a new growth opportunity. Based on your institution’s current situation and future vision, it would be a good time to start considering what options are available with experts.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a certified M&A support institution by the Small and Medium Enterprise Agency, with a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here.